Presentation TCT 2013 Is Normalized Vasoreactivity at and Distal to the Stent Site Likely to Translate into Improved Clinical Outcomes? Presenter: Raimund Erbel October 27, 2013
Presentation TCT 2013 Chemical Ablation for Renal Denervation (Northwind Technologies) Presenter: Mark Wholey October 27, 2013
Presentation TCT 2012 Position 1. Use PCI and DES Sparingly, and if at All, Only After OMT Truly Fails! Presenter: David Brown October 22, 2012
Presentation TCT 2012 Case 4: My Own Complex Retrograde Approach Presenter: R. Michael Wyman October 25, 2012
Presentation TCT 2012 Old and New Strategies to Reduce D2B Times Presenter: Sameer Mehta October 26, 2012
Presentation TCT 2012 My Criteria for Selecting Transapical TAVR (vs. Transfemoral TAVR or Open Surgery) Presenter: Rudiger Lange October 22, 2012
Presentation TCT 2012 Concomitant CAD and Aortic Stenosis: Implications and Revascularization Strategies Presenter: David Hildick-Smith October 22, 2012
Presentation TCT 2012 Stroke Risk After TAVR: Results from a Large Meta-analysis Presenter: Raimund Erbel October 22, 2012
Presentation TCT 2012 New Pacemakers After TAVR: Frequency, Predictors, Clinical Outcomes, and Guidelines on “When to Treat” Presenter: Jeffrey Popma October 22, 2012